Pimozide

Generic Name
Pimozide
Brand Names
Orap
Drug Type
Small Molecule
Chemical Formula
C28H29F2N3O
CAS Number
2062-78-4
Unique Ingredient Identifier
1HIZ4DL86F
Background

A diphenylbutylpiperidine that is effective as an antipsychotic agent and as an alternative to haloperidol for the suppression of vocal and motor tics in patients with Tourette syndrome. Although the precise mechanism of action is unknown, blockade of postsynaptic dopamine receptors has been postulated. (From AMA Drug Evaluations Annual, 1994, p403)

Indication

适用于急、慢性精神分裂症,对精神分裂症的阴性症状疗效较好,亦可用于治疗偏执状态、亨廷顿病、抽动秽语综合征、躁狂症、神经性厌食、青少年行为障碍等。

Associated Conditions
Delusional Parasitosis, Tics
Associated Therapies
-

Electrophysiological Effects of Potential QT Prolonging Drugs

First Posted Date
2023-02-08
Last Posted Date
2023-06-22
Lead Sponsor
Food and Drug Administration (FDA)
Target Recruit Count
44
Registration Number
NCT05716854
Locations
🇺🇸

Spaulding Clinical Research, West Bend, Wisconsin, United States

Pharmacovigilance in Gerontopsychiatric Patients

Phase 3
Terminated
Conditions
Interventions
Drug: Phenobarbital
Drug: Phenytoin
Drug: Carbamazepine
Drug: Oxcarbazepine
Drug: Valproic Acid
Drug: Lamotrigine
Drug: Topiramate
Drug: Gabapentin
Drug: Levetiracetam
Drug: Pregabalin
Drug: Lacosamide
Drug: Clonazepam
Drug: Biperiden
Drug: Levomepromazine
Drug: Fluphenazine
Drug: Perphenazine
Drug: Perazine
Drug: Thioridazine
Drug: Haloperidol
Drug: Melperone
Drug: Pipamperone
Drug: Bromperidol
Drug: Benperidol
Drug: Sertindole
Drug: Ziprasidone
Drug: Flupentixol
Drug: Chlorprothixene
Drug: Zuclopenthixol
Drug: Fluspirilene
Drug: Pimozide
Drug: Clozapine
Drug: Olanzapine
Drug: Quetiapine
Drug: Sulpiride
Drug: Tiapride
Drug: Amisulpride
Drug: Prothipendyl
Drug: Risperidone
Drug: Aripiprazole
Drug: Paliperidone
Drug: Diazepam
Drug: Oxazepam
Drug: Lorazepam
Drug: Bromazepam
Drug: Clobazam
Drug: Alprazolam
Drug: Hydroxyzine
Drug: Buspirone
Drug: Chloral Hydrate
Drug: Flurazepam
Drug: Nitrazepam
Drug: Triazolam
Drug: Lormetazepam
Drug: Temazepam
Drug: Midazolam
Drug: Brotizolam
Drug: Zopiclone
Drug: Zolpidem
Drug: Zaleplon
Drug: Melatonin
Drug: Clomethiazole
Drug: Diphenhydramine
Drug: Promethazine
Drug: Imipramine
Drug: Clomipramine
Drug: Opipramol
Drug: Trimipramine
Drug: Amitriptyline
Drug: Nortriptyline
Drug: Doxepin
Drug: Maprotiline
Drug: Amitriptyline oxide
Drug: Fluoxetine
Drug: Citalopram
Drug: Paroxetine
Drug: Sertraline
Drug: Fluvoxamine
Drug: Escitalopram
Drug: Tranylcypromine
Drug: Moclobemide
Drug: Mianserin
Drug: Trazodone
Drug: Mirtazapine
Drug: Bupropion
Drug: Venlafaxine
Drug: Reboxetine
Drug: Duloxetine
Drug: Agomelatine
Drug: Pyritinol
Drug: Piracetam
Drug: Donepezil
Drug: Rivastigmine
Drug: Galantamine
Drug: Memantine
Drug: Nicergoline
Drug: Acamprosate
Drug: Lithium
First Posted Date
2015-03-02
Last Posted Date
2018-02-28
Lead Sponsor
Hannover Medical School
Target Recruit Count
407
Registration Number
NCT02374567
Locations
🇩🇪

Bezirkskrankenhaus Augsburg, Augsburg, Germany

🇩🇪

Krankenhaus Hedwigshöhe, Berlin, Germany

🇩🇪

Hannover Medical School, Hannover, Germany

and more 2 locations

Efficacy of Pimozide Augmentation for Clozapine Partial Response

Phase 2
Completed
Conditions
Interventions
First Posted Date
2006-09-11
Last Posted Date
2016-03-04
Lead Sponsor
Yale University
Target Recruit Count
28
Registration Number
NCT00374244
Locations
🇺🇸

Connecticut Mental Health Center, New Haven, Connecticut, United States

🇺🇸

VA Connecticut Healthcare System, West Haven, Connecticut, United States

Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia

First Posted Date
2005-09-12
Last Posted Date
2015-04-09
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
76
Registration Number
NCT00158223
Locations
🇺🇸

Pilgrim Psychiatric Center, W. Brentwood, New York, United States

🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

🇺🇸

Manhattan Psychiatric Center, New York, New York, United States

Phase II Pilot Controlled Study of Short Vs Longer Term Pimozide (Orap) Therapy in Tourette Syndrome

Phase 2
Completed
Conditions
First Posted Date
2000-02-25
Last Posted Date
2005-06-24
Lead Sponsor
National Center for Research Resources (NCRR)
Target Recruit Count
20
Registration Number
NCT00004652
© Copyright 2024. All Rights Reserved by MedPath